Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1996-09-13
1999-02-09
Saunders, David
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
204452, 204461, 435268, 435274, 435810, 436 94, 436172, 436175, 536 187, 536123, 5361231, 53612313, C07H 100, G01N 3350
Patent
active
058692738
ABSTRACT:
The subject invention provides methods and kits for detecting increased bone resorption in patients. These methods and kits use chondroitin sulfate, a glycosaminoglycan, as a marker for bone resorption. Levels of chondroitin sulfate are detected in samples of urine or serum taken from patients. Measurements of chondroitin sulfate levels are made by methods such as fluorophore-assisted carbohydrate electrophoresis (FACE). Knowledge of increased bone resorption rates is useful in diagnosis of bone disorders such as osteoporosis.
REFERENCES:
patent: 4385046 (1983-05-01), Milbrath et al.
patent: 4468465 (1984-08-01), Sato
patent: 5019231 (1991-05-01), Brandley et al.
patent: 5185245 (1993-02-01), Heimer
patent: 5205917 (1993-04-01), Klock, Jr.
patent: 5427954 (1995-06-01), Sandy et al.
patent: 5569366 (1996-10-01), Chen et al.
Hood et al, Immunology, Second Edition, Benjamin/Cummings Publishing-Company, Inc., 1984, pp. 66-70.
Caterson et al, In Wight et al (EDS), Biology of Proteoglycans, Academic Press, Inc., 1987, pp. 1-26.
J. Liu et al, Jour. Chromat., 559, 223-235, 1991.
Bettica et al. (1992), "Bone-Resorption Markers Galactosyl Hydroxylysine, Pyridinium Crosslinks, and Hydroxyproline Compared", Clinical Chemistry 38:2313-18.
Falch (1994), "Can Biochemical Markers Tell Us Anything About Rate of Bone Loss" Scand. J. Clin. Lab. Invest. (Suppl. 219) 54:40-41.
Farley et al. (1995), "Skeletal Alkaline Phosphatase Activity in Serum", Clin. Chem. 41:1551-53.
Garnero et al. (1994), "Comparison of New Biochemical Markers of Bone Turnover in Late Postmenopausal Osteoporotic Women in Response to Alendronate Treatment", J. Clin. Endocrinol. Metab. 79:1693-1700.
Gertz et al. (1994), "Monitoring Bone Resorption in Early Postmenopausal Women by an Immunoassay for Cross-Lined Collagen Peptides in Urine", J. Bone Mineral Res. 9:135-42.
Hanson et al. (1992), "A Specific Immunoassay for Monitoring Human Bone Resorption: Quantitation of Type I Collagen Cross Linked N-Telopeptides in Urine", J. Bone Mineral Res. 7:1251-58.
Klock et al., 1995, "The Different Faces of Disease, FACE.RTM. Diagnosis of Disease" Glycoimmunology 2:13-25.
Klock et al., 1994, "The Different FACEs of Disease," Abstract of Third Jenner Glycoimmunology Meeting.
Larking et al. (1987), "Urine Glycosaminoglyscans in a Reference Population: Effects of Age, Body Surface Area, and Postmenopausal Status", Biochem. Med. Metabol. Biol. 37:246-54.
McCarroll (1993), "Bone Disorders (Osteoporosis)", Analytical Chem. 65:388R-95R.
Poulsen (1981), "An Electrophoretic Fraction of Urinary Glycosaminoglyscans Reflecting Connective Tissue Turnover", Scand. J. Clin. Lab. Invest. 41:675-81.
Reeve et al. (1995), "Evoluation of Spinal Bone Loss and Biochemical Markers of Bone Remodeling After menopause in Normal Women", Calcified Tissue Int'l. 57:105-10.
Seibel et al., 1993 "Urinary Hydroxypyridinium Crosslinks of Collagen as Markers of Bone Resorption and Estrogen Efficacy in Postmenopausal Osteoporosis", Journal of Bone and Mineral Research 8:881-888.
Seyedin et al. (1993), "Immunoassay for Urinary Pyridinoline: The New Marker for Bone Resorption", J. Bone Mineral Res. 8:635-41.
Todorova et al. (1992), "Urinary Excretion of Glycoasaminoglycans in Patients with Postmenopausal Osteoporosis", Horm. Metab. Res. 24:585-87.
Valimaki et al. (1994), "Bone Resorption in Healthy and Osteoporotic Postmenopausal Women: Comparison Markers for Serum Carboxy-Terminal Telopeptide of Type I Collagen and Urinary Pyridinium Cross-Links", Eur. J. Endocrinol. 131:258-62.
WHO Technical Report #843 (1984) "Assesment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis" pp. 1-122.
Glyko, Inc.
Saunders David
LandOfFree
Chondroitin sulfate as a marker of bone resorption does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chondroitin sulfate as a marker of bone resorption, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chondroitin sulfate as a marker of bone resorption will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1947715